202 related articles for article (PubMed ID: 3469935)
1. [Cefmenoxime or piperacillin plus amikacin. A prospective randomized comparison of empiric antibiotic therapy of febrile granulocytopenic cancer patients].
Sampi K; Kumai R; Maseki N; Sakurai M; Kaneko Y; Hattori M
Gan To Kagaku Ryoho; 1987 Mar; 14(3 Pt 1):674-9. PubMed ID: 3469935
[TBL] [Abstract][Full Text] [Related]
2. A double beta-lactam combination versus an aminoglycoside-containing regimen as empiric antibiotic therapy for febrile granulocytopenic cancer patients.
De Jongh CA; Joshi JH; Thompson BW; Newman KA; Finley RS; Moody MR; Salvatore PC; Tenney JH; Drusano GL; Schimpff SC
Am J Med; 1986 May; 80(5C):101-11. PubMed ID: 3521269
[TBL] [Abstract][Full Text] [Related]
3. [Comparative study of cefpiramide + amikacin versus piperacillin + amikacin in granulocytopenic patients: a randomized, prospective study].
Sampi K; Hattori M
Gan To Kagaku Ryoho; 1992 Aug; 19(9):1315-20. PubMed ID: 1503486
[TBL] [Abstract][Full Text] [Related]
4. Imipenem/cilastatin versus amikacin plus piperacillin in the treatment of infections in neutropenic patients: a prospective, randomized multi-clinic study.
Norrby SR; Vandercam B; Louie T; Runde V; Norberg B; Anniko M; Andrien F; Baudrihaye M; Bow E; Burman LA
Scand J Infect Dis Suppl; 1987; 52():65-78. PubMed ID: 3331044
[TBL] [Abstract][Full Text] [Related]
5. Piperacillin plus amikacin therapy v carbenicillin plus amikacin therapy in febrile, granulocytopenic patients.
Winston DJ; Ho WG; Young LS; Hewitt WL; Gale RP
Arch Intern Med; 1982 Sep; 142(9):1663-7. PubMed ID: 6214228
[TBL] [Abstract][Full Text] [Related]
6. Piperacillin or ticarcillin plus amikacin. A double-blind prospective comparison of empiric antibiotic therapy for febrile granulocytopenic cancer patients.
Wade JC; Schimpff SC; Newman KA; Fortner CL; Standiford HC; Wiernik PH
Am J Med; 1981 Dec; 71(6):983-90. PubMed ID: 6459027
[TBL] [Abstract][Full Text] [Related]
7. Treatment of febrile episodes in neutropenic leukemic patients with the antibiotic combinations piperacillin or ceftazidime plus amikacin: results of a randomized study.
Fenu S; Raccah R; Santilli S; Micozzi A; Girmena C; Martino P; Avvisati G
Chemioterapia; 1988 Oct; 7(5):323-6. PubMed ID: 3066517
[TBL] [Abstract][Full Text] [Related]
8. [Empiric therapy with piperacillin plus amikacin for febrile patients with cancer--with emphasis on granulocytopenia].
Sampi K; Kumai R; Sakurai M; Kaneko Y; Hattori M
Gan To Kagaku Ryoho; 1985 Jun; 12(6):1301-5. PubMed ID: 4004291
[TBL] [Abstract][Full Text] [Related]
9. Meropenem plus amikacin versus piperacillin-tazobactam plus netilmicin as empiric therapy for high-risk febrile neutropenia in children.
Aksoylar S; Cetingül N; Kantar M; Karapinar D; Kavakli K; Kansoy S
Pediatr Hematol Oncol; 2004 Mar; 21(2):115-23. PubMed ID: 15160510
[TBL] [Abstract][Full Text] [Related]
10. Amikacin plus ceftazidime versus amikacin plus piperacillin versus amikacin plus aztreonam in infections in neoplastic patients with granulocytopenia.
Casali A; Ameglio F; Gionfra T; Tonachella R; Paoletti G; Gallo Curcio C
Chemioterapia; 1987 Dec; 6(6):440-4. PubMed ID: 3325175
[TBL] [Abstract][Full Text] [Related]
11. Piperacillin plus amikacin versus cefotaxime plus amikacin in neutropenic and feverish patients with malignant hemopathies.
Pavone V; Specchia G; Guarini A; Coniglio M; Iaculli L; Girardi F; Colucci A; Liso V
Chemioterapia; 1988 Oct; 7(5):330-5. PubMed ID: 3224402
[TBL] [Abstract][Full Text] [Related]
12. Empiric antimicrobial therapy in febrile granulocytopenic patients. Randomized prospective comparison of amikacin plus piperacillin with or without parenteral trimethoprim/sulphamethoxazole.
Menichetti F; Del Favero A; Guerciolini R; Tonato M; Aversa F; Roila F; Frongillo RF; Martelli MF; Davis S; Pauluzzi S
Infection; 1986; 14(6):261-7. PubMed ID: 3546144
[TBL] [Abstract][Full Text] [Related]
13. [Empiric therapy with piperacillin plus amikacin in febrile granulocytopenic patients with acute leukemia].
Sampi K; Kumai R; Maseki N; Sakurai M; Kaneko Y; Hattori M
Rinsho Ketsueki; 1986 Nov; 27(11):2065-9. PubMed ID: 3469434
[No Abstract] [Full Text] [Related]
14. Vancomycin added to empirical combination antibiotic therapy for fever in granulocytopenic cancer patients. European Organization for Research and Treatment of Cancer (EORTC) International Antimicrobial Therapy Cooperative Group and the National Cancer Institute of Canada-Clinical Trials Group.
J Infect Dis; 1991 May; 163(5):951-8. PubMed ID: 2019772
[TBL] [Abstract][Full Text] [Related]
15. Moxalactam plus piperacillin versus moxalactam plus amikacin in febrile granulocytopenic patients.
Winston DJ; Barnes RC; Ho WG; Young LS; Champlin RE; Gale RP
Am J Med; 1984 Sep; 77(3):442-50. PubMed ID: 6475984
[TBL] [Abstract][Full Text] [Related]
16. Empiric antibiotic therapy with an amikacin-carbenicillin-cefoxitin combination in granulocytopenic febrile patients--a clinical report.
Fernández-Rañada J; Fernández-Garese D; Caretti D; Vázquez L; Escudero A; Olmeda F
Int J Clin Pharmacol Ther Toxicol; 1983 Oct; 21(10):511-3. PubMed ID: 6642788
[TBL] [Abstract][Full Text] [Related]
17. Prospective randomized evaluation of ciprofloxacin versus piperacillin plus amikacin for empiric antibiotic therapy of febrile granulocytopenic cancer patients with lymphomas and solid tumors. The European Organization for Research on Treatment of Cancer International Antimicrobial Therapy Cooperative Group.
Meunier F; Zinner SH; Gaya H; Calandra T; Viscoli C; Klastersky J; Glauser M
Antimicrob Agents Chemother; 1991 May; 35(5):873-8. PubMed ID: 1854169
[TBL] [Abstract][Full Text] [Related]
18. [Piperacillin and amikacin in the treatment of infections in neoplasm patients with granulocytopenia].
Giaccone G; Bagatella M; Donadio M; Bonardi GM; Calciati A
Clin Ter; 1989 Aug 15-31; 130(3-4):191-5. PubMed ID: 2529094
[TBL] [Abstract][Full Text] [Related]
19. A prospective, controlled, randomized, non-blind, comparative study of the efficacy and safety of a once daily high dose of ceftriaxone plus ciprofloxacin versus thrice daily ceftazidime plus amikacin in empirical therapy for febrile neutropenic patients.
Metallidis S; Kollaras P; Giannakakis T; Seitanidis B; Kordosis T; Nikolaidis J; Hatzitolios A; Nikolaidis P
Eur J Intern Med; 2008 Dec; 19(8):619-24. PubMed ID: 19046729
[TBL] [Abstract][Full Text] [Related]
20. Piperacillin-tazobactam plus amikacin as an initial empirical therapy of febrile neutropenia in paediatric cancer patients.
Hamidah A; Rizal AM; Nordiah AJ; Jamal R
Singapore Med J; 2008 Jan; 49(1):26-30. PubMed ID: 18204765
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
